CHU Amiens
Amiens, 80480, France
NCT Number: NCT04938479
Cerebral infarction is the leading cause of acquired disability in adults. Absence of biological marker used in current practice and identified as a prognostic factor for recovery. D-dimers are degradation products of stabilized fibrin translating an activation of coagulation whatever the cause. Studies have shown that increased D-dimer levels in patients with MI is associated with a higher mortality rate, the link with post-intervention non-revascularization has been demonstrate.
The purpose of this project is to search for a correlation between the level of D-dimer and the degree of recovery evaluated by the NIHSS score
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Amiens, 80480, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
D-dimer measurement in blood sample
Time frame: 3 months
NIHSS score is based on the clinical neurological examination of the patient. Validated by the scientific community of vascular neurology, among other things in projective clinical research. This score has high inter-observer reproducibility Expressed quantitatively on a scale of 0 to 42 for the NIHSS score A high value of the NIHSS score indicates poor recovery.
Time frame: 6 months
NIHSS score is based on the clinical neurological examination of the patient. Validated by the scientific community of vascular neurology, among other things in projective clinical research. This score has high inter-observer reproducibility Expressed quantitatively on a scale of 0 to 42 for the NIHSS score A high value of the NIHSS score indicates poor recovery.
Time frame: 3 months
Rankin Scale collected by the neurologist in consultation 3-6 months post stroke.
Expressed quantitatively on a scale of 0 to 6 for the Rankin scale. A high value of the Rankin scale indicates poor recovery.
Time frame: 6 months
Rankin Scale collected by the neurologist in consultation 3-6 months post stroke.
Expressed quantitatively on a scale of 0 to 6 for the Rankin scale. A high value of the Rankin scale indicates poor recovery.
Centre Hospitalier Universitaire, Amiens
Other
Acronym: D-Dimer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00200356
Brain Diseases, Brain Infarction
View Trial DetailsNCT04238260
Behavior, Brain Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT06935279
Arterial Occlusive Diseases, Arteriosclerosis
Xian, Shanxi, China
View Trial DetailsNCT00147316
Brain Diseases, Brain Infarction
Suita, Osaka, Japan
View Trial Details